283 – Post-Hoc Comparison of AS01B, MF59, and Alum Adjuvants Across 4 HIV Vaccine Trials
Background Vaccine adjuvants enhance humoral and cellular responses but may induce reactogenicity. AS01B, MF59, and Alum have distinct mechanisms, yet head-to-head comparisons of immunogenicity and reactogenicity are scarce. Methods We conducted a cross-protocol, post-hoc, analysis of four randomized, controlled, double-blind trials (HVTN 100, 107, 120, and 702) of adults without HIV who received ALVAC-HIV (vCP2438)…